VERAXA Biotech advances VXA-222 bispecific ADC program with OmniAb

Go back to VERAXA Biotech advances VXA-222 bispecific ADC program with OmniAb
(NASDAQ: OABI) Delayed: 4.54 -0.12 (2.58%)
Previous Close $4.66    52 Week High $ 
Open $4.66    52 Week Low $ 
Day High $4.72    P/E N/A 
Day Low $4.53    EPS $ 
Volume 365,666       

(NASDAQ: VRXA) Delayed: 0.98 -0.02 (2%)
Previous Close $1.00    52 Week High $ 
Open $1.00    52 Week Low $ 
Day High $1.03    P/E N/A 
Day Low $0.95    EPS $ 
Volume 148,381